High-mobility group A1a protein regulates Ras/ERK signaling in MCF-7 human breast cancer cells

Oncogene

Volumn 23, Issue 3, 2004, Pages 777-785

  Treff, Nathan R ^a   Pouchnik, Derek ^a   Dement, Gregory A ^a   Britt, Rachel L ^a   Reeves, Raymond ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

Caveolin; Cholesterol; HMGA1; KIT ligand; MCF 7 cells; Ras ERK

Indexed keywords

CAVEOLIN 1; CAVEOLIN 2; CHOLESTEROL; EPIDERMAL GROWTH FACTOR; HIGH MOBILITY GROUP A1A PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; RAS PROTEIN; STEM CELL FACTOR;

ARTICLE; BREAST CANCER; CANCER CELL; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GENE CONTROL; GENE EXPRESSION; HUMAN; HUMAN CELL; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; BASE SEQUENCE; BREAST NEOPLASMS; CELL LINE, TUMOR; DNA PRIMERS; GENE EXPRESSION PROFILING; HIGH MOBILITY GROUP PROTEINS; MITOGEN-ACTIVATED PROTEIN KINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

MINK CELL FOCUS-FORMING VIRUS;

EID: 1242340498     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207167     Document Type: Article

References (60)

1. Abe N, Watanabe T, Masaki T, Mori T, Sugiyama M, Uchimura H, Fujioka Y, Chiappetta G, Fusco A and Atomi Y. (2000). Cancer Res., 60, 3117-3122.
2. Bandiera A, Bonifacio D, Manfioletti G, Mantovani F, Rustighi A, Zanconati F, Fusco A, Bonito LD and Giancotti V. (1998). Cancer Res., 58, 426-431.
3. Banks GC, Li Y and Reeves R. (2000). Biochemistry, 39, 8333-8346.
4. Beckerbauer L, Tepe JJ, Cullison J, Reeves R and Williams M. (2000). Chem. Biol., 7, 805-812.
5. Berlingieri MT, Manfioletti G, Santoro M, Bandiera A, Visconti R, Giancotti V and Fusco A. (1995). Mol. Cellu. Biol., 15, 1545-1553.
6. Brandt S, Kopp A, Grage B and Knabbe C. (2003). Anticancer Res., 23, 223-229.
7. Bustin M. (2001). Trends Biochem. Sci., 26, 152-153.
8. Bustin M and Reeves R. (1996). Prog. Nucleic Acids Res., 54, 25-100.
9. Caceres-Cortes JR, Alvarado-Moreno JA, Waga K, Rangel-Corona R, Monroy-Garcia A, Rocha-Zavaleta L, Urdiales-Ramos J, Weiss-Steider B, Haman A, Hugo P, Brousseau R and Hoang T. (2001). Cancer Res., 61, 6281-6289.
10. Charpentier AH, Bednarek AK, Daniel RL, Hawkins KA, Laflin KJ, Gaddis S, McLeod MC and Aldaz MC. (2000). Cancer Res., 60, 5977-5983.
11. Chen Y-W, Zhao P, Borup R and Hoffman EP. (2000). J. Cell Biol., 151, 1321-1336.
12. Chiappetta G, Bandiera A, Berlingieri MT, Visconti R, Manfioletti G, Battista S, Martinex-Tello FJ, Santoro M, Giancotti V and Fusco A. (1995). Oncogene, 10, 1307-1314.
13. Dahlquist KD. (2002). Nat. Genet., 31, 19-20.
14. Daoud SS, Munson PJ, Reinhold W, Young L, Prabhu VV, Yu Q, LaRose J, Kohn KW, Weinstein JN and Pommier Y. (2003). Cancer Res., 63, 2782-2793.
15. Doniger SW, Salomonis N, Dahlquist KD, Vranizan K, Lawlor SC and Conklin BR. (2003). Genome Biol., 4, R7.
16. Engelman JA, Chu C, Lin A, Jo H, Ikezu T, Okamoto T, Kohtz DS and Lisanti MP. (1998). FEBS Lett., 428, 205-211.
17. Fedele M, Bandiera A, Chiappetta G, Battista S, Viglietto G, Manfioletti G, Casamassami A, Santoro M, Giancotti V and Fusco A. (1996). Cancer Res., 56, 1896-1901.
18. Fiucci G, Ravid D, Reich R and Liscovitch M. (2002). Oncogene, 21, 2365-2375.
19. Friedmann M, Holth LT, Zoghbi H and Reeves R. (1993). Nucleic Acids Res., 21, 4259-4267.
20. Furuchi T and Anderson RG. (1998). J. Biol. Chem., 273, 21099-21104.
21. Giancotti V, Buratti E, Perissin L, Zorzet S, Balmain A, Portella G, Fusco A and Goodwin GH. (1989). Exp. Cell Res., 184, 538-545.
22. Giancotti V, Pani B, D'Andrea P, Berlingieri MT, DiFiore PP, Fusco A, Vecchio G, Philip R, Crane-Robinson C, Nicolas RH, Wright CA and Goodwin GH. (1987). EMBO J., 6, 1981-1987.
23. Giannini G, Di Marcotullio L, Ristori E, Zani M, Crescenzi M, Scarpa S, Piaggio G, Vacca A, Peverali FA, Diana F, Screpanti I, Frati L and Gulino A. (1999). Cancer Res., 59, 2484-2492.
24. Giannini G, Kim CJ, Marcotullio LD, Manfioletti G, Cardinali B, Cerignoli F, Ristori E, Zani M, Frati L, Screpanti I and Guilino A. (2000). Br. J. Cancer, 83, 1503-1509.
25. Heider JG and Boyett RL. (1978). J. Lipid Res., 19, 514-518.
26. Hilger RA, Scheulen ME and Strumberg D. (2002). Onkologie, 25, 511-518.
27. Janowski BA. (2002). Proc. Natl. Acad. Sci. USA, 99, 12675-12680.
28. Johnson KR, Lehn DA and Reeves R. (1988). J. Biol. Chem., 263, 18338-18342.
29. Johnson KR, Lehn DA and Reeves R. (1989). Mol. Cell. Biol., 9, 2114-2123.
30. Kaneda A, Kaminishi M, Nakanishi Y, Sugimura T and Ushijima T. (2002). Int. J. Cancer, 100, 57-62.
31. Kolch W. (2002). Expert Opin. Pharmacother., 3, 709-718.
32. Kopp A, Jonat W, Schmahl M and Knabbe C. (1995). Cancer Res., 55, 4512-4515.
33. Lee Jr JT and McCubrey JA. (2002). Leukemia, 16, 486-507.
34. Lee MT, Kuo FC, Whitmore GA and Sklar J. (2000). Proc. Natl. Acad. Sci. USA, 97, 9834-9839.
35. Lee S, Baek M, Yang H, Bang Y, Kim WH, Ha J, Kim D and Jeoung D. (2002). Cancer Lett., 184, 197-206.
36. Lennartsson J, Blume-Jensen P, Hermanson M, Ponten E, Carlberg M and Ronnstrand L. (1999). Oncogene, 18, 5546-5553.
37. Lundberg K, Karlson JR, Ingebrigtsen K, Holtlund J, Lund T and Leland SG. (1989). Biochim. Biophys. Acta, 1009, 277-279.
38. Marshall CJ. (1995). Cell, 80, 179-185.
39. Nam ES, Kim DH, Cho SJ, Chae SW, Kim HY, Kim SM, Han JJ, Shin HS and Park YE. (2003). Histopathology, 42, 466-471.
40. Ogram SA and Reeves R. (1995). J. Biol. Chem., 270, 14235-14242.
41. Pawson T and Scott JD. (1997). Science, 278, 2075-2080.
42. Peyssonnaux C and Eychene A. (2001). Biol. Cell, 93, 53-62.
43. Pierantoni GM, Agosti V, Fedele M, Bond H, Caliendo I, Chiappetta G, Lo Coco F, Pane F, Turco MC, Morrone G, Venuta S and Fusco A. (2003). Biochem. J., 15, 145-150.
44. Rajeswari MR, Singh D, Jain A and Ruma R. (2001). Cancer Lett., 173, 93-99.
45. Ram TG, Reeves R and Hosick HL. (1993). Cancer Res., 53, 2655-2660.
46. Reeves R. (2000). Environ. Health Perspect., 108 (Suppl. 5), 803-809.
47. Reeves R. (2001). Gene, 277, 63-81.
48. Reeves R and Beckerbauer L. (2001). Biochim. Biophys. Acta, 1519, 13-29.
49. Reeves R, Edberg D and Li Y. (2001). Mol. Cell. Biol., 21, 575-594.
50. Reeves R and Nissen MS. (1990). J. Biol. Chem., 265, 8573-8582.
51. Reeves R and Nissen MS. (1999). Methods Enzymol., 304, 155-187.
52. Scala S, Portella G, Fedele M, Chiappetta G and Fusco A. (2000). Proc. Natl. Acad. Sci. USA, 97, 4256-4261.
53. Smalley KS. (2003). Int. J. Cancer, 104, 527-532.
54. Tallini G and Dal Cin P. (1999). Adv. Anat. Pathol., 6, 237-246.
55. Tamimi Y, van der Poel HG, Denyn M, Umbas R, Karthaus HFM, Debruyne FMJ and Schalken JA. (1993). Cancer Res., 53, 5512-5516.
56. Thomas JO and Travers AA. (2001). Trends Biochem. Sci., 26, 167-174.
57. Weinstein-Oppenheimer CR, Blalock WL, Steelman LS, Chang F and McCubrey JA. (2000). Pharmacol. Ther., 88, 229-279.
58. Wood LJ, Maher JF, Bunton TE and Resar LMS. (2000a). Cancer Res., 60, 4256-4261.
59. Wood LJ, Mukherjee M, Dolde CE, Xu Y, Maher JF, Bunton TE, Williams JB and Resar LMS. (2000b). Mol. Cell. Biol., 20, 5490-5502.
60. Zhang W, Stoica G, Tasca SI, Kelly KA and Meininger CJ. (2000). Cancer Res., 60, 6757-6762.